Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Mimicking Human Cartilage to Repair a Knee
NY Times ^ | August 16, 2009 | ANNE EISENBERG

Posted on 08/16/2009 2:13:33 PM PDT by neverdem

ONE way for surgeons to repair injured knees is to take cartilage and bone from another part of the knee and transplant it in the damaged area.

Now companies are developing potentially simpler knee patches: small, off-the-shelf plugs engineered to mimic the composition of human bone and cartilage.

These ready-made cylinders can be inserted in an arthroscopic procedure; they are often used after a sports injury. They are known as osteochondral scaffolds, because they support new bone and cartilage as it grows.

Orthomimetics, a company in Cambridge, England, has developed a scaffold approved for use in Europe that resulted from a collaboration between faculty members at the Massachusetts Institute of Technology and the University of Cambridge.

The scaffold provides a temporary, engineered matrix when inserted into a drilled hole, said Lorna Gibson, a professor of materials science and engineering at M.I.T. and one of the inventors of the device. Stem cells from the bone marrow that can form bone or cartilage impregnate the pores of the cylinder.

“The scaffold guides the tissue formation of bone on one side and cartilage on the other,” Dr. Gibson said.

The scaffold disappears in about six months. “Over time the cells that attach to the scaffold produce enzymes that dissolve it,” Dr. Gibson said. At the same time, the cells are putting down their own matrix.

Dr. Constance R. Chu, director of the Cartilage Restoration Center at the University of Pittsburgh and the Albert Ferguson associate professor of orthopedic surgery and bioengineering, said that there were potential benefits to using the cylinders to help repair cartilage that protects bones in the knee joint from rubbing against one another.

“Surgeons can do effective repairs by borrowing bone and cartilage from another part of the knee” that is less weight-bearing, Dr. Chu said. “But people don’t...”

(Excerpt) Read more at nytimes.com ...


TOPICS: Culture/Society; News/Current Events; Technical
KEYWORDS: adultstemcells; arthroscopy; stemcellarthroscopy; stemcells

1 posted on 08/16/2009 2:13:33 PM PDT by neverdem
[ Post Reply | Private Reply | View Replies]

To: neverdem

thanks for the info


2 posted on 08/16/2009 2:17:01 PM PDT by kalee (01/20/13 The end of an error.... Obama even worse than Carter.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Eaker

Technology I ain’t got ping.


3 posted on 08/16/2009 2:19:07 PM PDT by humblegunner
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem

inneresting


4 posted on 08/16/2009 2:20:10 PM PDT by dennisw (Free Republic is an island in a sea of zombies)
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem

Interesting. I had hip replacement surgery two years ago at a fairly young age — for that kind of surgery — and my grown children are showing some of the same signs I did at their age. I’m hoping medicine will advance enough that the fix will be more simple than what I went through.


5 posted on 08/16/2009 2:27:10 PM PDT by PistolPaknMama (We're mad, but when do we get REALLY mad?)
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem

looks like perhaps the natural progression of the “mesh” that was a breakthrough for the pelvic side of hip replacements not so long ago....15 yrs or so ago, IIRC....


6 posted on 08/16/2009 2:29:40 PM PDT by Vn_survivor_67-68 (CALL CONGRESSCRITTERS TOLL-FREE @ 1-800-965-4701)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Pharmboy; Coleus; Peach; airborne; Asphalt; Dr. Scarpetta; I'm ALL Right!; StAnDeliver; ovrtaxt; ...
A screen for cancer killers

By silencing a specific gene in breast cancer cells, the researchers coaxed them to convert from epithelial cells, which make up most of the human body, into mesenchymal cells, which have many stem-cell-like characteristics. They then used these cells — which have the same molecular signatures as cancer stem cells and are equally drug resistant — to screen around 16,000 chemicals. They found 32 contenders, then whittled the list down to one drug: salinomycin, an antibiotic often found in animal feed.

I get the impression that they are preparing 16,000 mesenchymal cell cultures, one for each drug.

Pharmboy, correct me if I'm wrong.

7 posted on 08/16/2009 2:30:36 PM PDT by neverdem (Xin loi minh oi)
[ Post Reply | Private Reply | To 1 | View Replies]

To: kalee

Both knees are cheering as I write this. It’s a little embarrassing...I still gotta make my run times for 6 more years.

Colonel, USAFR


8 posted on 08/16/2009 2:53:57 PM PDT by jagusafr (Kill the red lizard, Lord! - nod to C.S. Lewis)
[ Post Reply | Private Reply | To 2 | View Replies]

To: jagusafr

I have torn the cartilage in my left knee, this sounds better than what they have recommended so far.


9 posted on 08/16/2009 3:04:58 PM PDT by kalee (01/20/13 The end of an error.... Obama even worse than Carter.)
[ Post Reply | Private Reply | To 8 | View Replies]

To: neverdem

Yep. They grew 1,600 separate cultures. That’s about 16 standard 96-well titer plates’ worth. Not even enough to fill a microwave oven.

They probably tested each chemical on scores of different cell lines.

Skilled human eyeballs had to look at each result.

Only 1 or 2% look promising at that stage, maybe 10% of those will pass enough of the following tests to even be considered for drug trials.

Most drugs fail the trials.

That, sir, is why the new wonder drugs are expensive.

Without the big payoff, no for profit company would risk all the time and money involved...


10 posted on 08/16/2009 3:09:19 PM PDT by null and void (We are now in day 207 of our national holiday from reality. - 0bama really isn't one of US.)
[ Post Reply | Private Reply | To 7 | View Replies]

To: neverdem
My brother just underwent knee surgery, so I sent him this link. In 5-10 years (when he needs the other one done) this should be standard procedure.

Thanks for sharing, FRiend!

11 posted on 08/16/2009 3:38:00 PM PDT by airborne (Don't let history record that, when faced with evil, you did nothing!)
[ Post Reply | Private Reply | To 7 | View Replies]

To: neverdem
Indeed...that what it sounds like (although I am in the pharmaceutical industry, this is not the end of the business I am expert in).

The 16,000 number sounds daunting, but remember this process is highly automated and can be accomplished fairly quickly.

12 posted on 08/16/2009 6:14:59 PM PDT by Pharmboy (Who ever thought we would long for the days of the Clinton administration...)
[ Post Reply | Private Reply | To 7 | View Replies]

To: neverdem
Discovered by creation scientists? Of course not.

Discovered by real scientists.

13 posted on 08/16/2009 6:39:40 PM PDT by Salman
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem

I need some of this!


14 posted on 08/16/2009 6:59:05 PM PDT by MadelineZapeezda (Have you girded your loins today??????)
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem
The last sentence of the article:

“Every cartilage repair technique works better in the young.”

15 posted on 08/16/2009 9:48:03 PM PDT by Dr. Scarpetta
[ Post Reply | Private Reply | To 1 | View Replies]

To: kalee

I’ve had both knees scoped and cartilage removed, AND an ACL replacement many moons ago. Anything that promises to make them ache less is a good thing. Good luck with yours.

Colonel, USAFR


16 posted on 08/17/2009 7:10:26 AM PDT by jagusafr (Kill the red lizard, Lord! - nod to C.S. Lewis)
[ Post Reply | Private Reply | To 9 | View Replies]

To: jagusafr

Thanks, hope you get relief for your knees too.


17 posted on 08/17/2009 7:17:28 AM PDT by kalee (01/20/13 The end of an error.... Obama even worse than Carter.)
[ Post Reply | Private Reply | To 16 | View Replies]

To: neverdem
Lilly abandons plan to submit arzoxifene for FDA review

"Eli Lilly and Co. said it will not submit its osteoporosis medicine arzoxifene for FDA review after the drug failed to meet certain clinical goals in a Phase III clinical trial. The Indianapolis drug firm will take an after-tax charge of $35 million to $45 million for discontinuing arzoxifene's development."

That $35-45,000,000 has to come from somewhere...

18 posted on 08/19/2009 8:38:19 AM PDT by null and void (We are now in day 210 of our national holiday from reality. - 0bama really isn't one of US.)
[ Post Reply | Private Reply | To 7 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson